image
Galmed Pharmaceuticals Ltd. GLMD
Healthcare - Biotechnology - NASDAQ - IL
Watchlist
$ 2.93
-5.48 %
$ 4.42 M
Market Cap
-0.27
P/E
BALANCE SHEET
16.6 M ASSETS
0.41%
Growth Rates
1Year 0.41%
3Years -31.78%
5Years -28.76%
7Years 0.15%
10Years 58.52%
2.75 M LIABILITIES
-12.36%
Growth Rates
1Year -12.36%
3Years -30.60%
5Years 0.32%
7Years -9.13%
10Years 2.65%
13.9 M EQUITY
3.40%
Growth Rates
1Year 3.40%
3Years -32.01%
5Years -30.87%
7Years 3.28%
10Years 24.73%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Galmed Pharmaceuticals Ltd.
image
Current Assets 13.2 M
Cash & Short-Term Investments 12.6 M
Receivables 165 K
Other Current Assets 432 K
Non-Current Assets 3.39 M
Long-Term Investments 3.26 M
PP&E 125 K
Other Non-Current Assets 0
Current Liabilities 2.75 M
Accounts Payable 1.88 M
Short-Term Debt 41 K
Other Current Liabilities 830 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 2.9 2.0 2.9 6.9 15.9 24.2 13.0 3.1 4.2 23.7 0.1 0.7
Short Term Investments 9.8 11.8 31.9 43.9 59.6 66.0 6.0 12.4 18.8 8.2 0 0
Receivables 0.2 0 0 0 0 51 K 0.2 0.3 0.1 64 K 11 K 10 K
Inventory 0 0.1 (0.9) (3.8) (27.9) 0 100 K (0.3) (0.3) (5.9) 0 0
Other Current Assets 0.4 0.7 1.2 0.9 0.9 0.2 100 K 0.3 0.3 0.1 5 K 4 K
Total Current Assets 13.2 14.7 36.1 51.8 76.4 90.4 19.2 15.7 23.4 32.2 0.2 0.7
PP&E 0.1 0.3 0.6 0.6 0.7 0.2 0.5 0.7 0.9 0.8 13 K 30 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 3.3 1.5 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 16.6 16.6 36.6 52.4 77.1 90.6 19.6 16.4 24.3 32.9 0.2 0.8
LIABILITIES
Accounts Payable 1.9 2.6 4.9 7.0 6.0 1.8 2.3 3.1 2.3 0.9 1.4 0.4
Short Term Debt 41 K 0.2 0 0 0 0 0 0 0 0 0 20 K
Other Current Liabilities 0.8 0.4 1.0 1.0 0.9 0.9 1.0 0.4 0.3 0.2 0.3 92 K
Total Current Liabilities 2.8 3.1 5.9 8.0 6.9 2.7 3.8 4.6 2.5 1.1 1.7 0.5
Long Term Debt 0 44 K 0.2 0.2 0.4 0 0 0 0 0 0 1.8
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0.3 0.2 0.4 0.4 0.4
Total Liabilities 2.8 3.1 6.1 8.2 7.3 2.7 3.8 5.4 2.7 1.5 2.1 2.7
EQUITY
Common Stock 0.2 70 K 70 K 58 K 58 K 58 K 40 K 34 K 32 K 32 K 20 K 7 K
Retained Earnings (193.0) (186.0) (168.2) (135.7) (106.9) (86.5) (76.6) (64.3) (47.4) (36.7) (27.6) (10.2)
Other Accumulative Comprehensive Income/Loss (0.5) (0.7) (0.2) 0.3 35 K 11 K 7 K 85 K (0.2) 4 K 17 K 17 K
Total Equity 13.9 13.4 30.5 44.2 69.9 87.9 15.8 11.1 21.5 31.4 (2.0) (2.0)
Total Liabilities and Equity 16.6 16.6 36.6 52.4 77.1 90.6 19.6 16.4 24.3 32.9 0.2 0.8
SHARES OUTSTANDING
Common Shares Outstanding 0.2 1.7 1.6 1.4 1.4 1.2 0.8 0.8 0.7 0.7 0.7 0.3